Brief: Scancell Initiates New Arm In SCOPE Phase 2 Study
25/06/2025 07:40
June 25 (Reuters) - Scancell Holdings PLC SCLP.L: SCANCELL HLDS - SCANCELL INITIATES NEW ARM IN SCOPE PHASE 2 STUDY SCANCELL HOLDINGS PLC - NO SIGNIFICANT ADVERSE EVENTS IN INITIAL 8 PATIENTS SCANCELL HOLDINGS PLC - INTERIM DATA FROM COHORT 4 EXPECTED YEAR-END SCANCELL HOLDINGS PLC - ADDITIONAL DATA FROM COHORTS 1-3 EXPECTED IN JULY 2025 Source text: ID:nRSY2491Oa Further company coverage: SCLP.L ((Reuters.Briefs@thomsonreuters.com;))